High performing – unique – clinically proven
Visco booster with dual effect based on hyaluronic acid combined with niacinamide.
Dual effect
1 Hummer, C.D., Angst, F., Ngai, W. et al. High molecular weight Intraarticular hyaluronic acid for the treatment of knee osteoarthritis: a network meta-analysis. BMC Musculoskelet Disord 21, 702 (2020). https://doi.org/10.1186/s12891-020-03729-w
2 Ogata S, Takeuchi M, Teradaira S, Yamamoto N, Iwata K, Okumura K, Taguchi H. Radical scavenging activities of niacin related compounds. Biosci Biotechnol Biochem. 2002 Mar;66(3):641-5. doi: 10.1271/bbb.66.641. PMID: 12005062
3 Jonas WB, Rapoza CP, Blair WF. The effect of niacinamide on osteoarthritis: a pilot study. Inflamm Res. 1996 Jul; 45(7):330-4. doi: 10.1007/BF02252945. PMID: 8841834
4 Atlantic Bone Screen, assigned by ALBOMED GmbH. In-vitro evaluation of the anti-hypertrophic effect of 1 product on rat chondrocytes. 2019
INNORYOS®
The first visco booster
The first visco booster for osteoarthritis patients with dual effect of hyaluronic acid and niacinamide (antioxidative effect, limits inflammation) shows best overall functional behavior for dynamic activities:
- Counterbalances the deleterious effect of osteoarthritis on synovial fluid
- Reinforces the gel with unique antioxidant properties
- Exhibits a high resistance to oxidative degradation
- Creates van-der-Waals bonds between hyaluronic acid chains for cross-stabilization
- Offers exceptional lubricating and shock-absorbing properties, resulting in optimal protection of the articular cartilage
Altogether, INNORYOS® maximizes the osteoarthritis treatment outcomes.
Key facts of INNORYOS®:
- Well-targeted molecular weight
- Ultra pure hyaluronic acid (bio-fermented) plus niacinamide
- Clinical evidence confirmed
- For main orthopaedic synovial joints
- Double sterile barrier system (by steam); suitable for OR use
- Shelf life: 42 month
- CE certified
Data table
Below you will find the specification of the INNORYOS® product line, including the color coding that helps to easily distinguish between the different concentrations.
|
Specification
|
INNORYOS®
|
|---|---|
|
Concentration
|
2.2 % hyaluronic acid, 1.5 % niacinamide
|
|
Molecular weight* (MDa)
|
1.2–2.2
|
|
Viscosity* (mPas)
|
370 000
|
|
Volume (ml)
|
2.0
|
|
Forms of therapy
|
1 to 5 injections
|
|
Storage
|
2–25 °C
|
* mean value after steam sterilization
News
Stay informed: keep yourself up-to-date with the latest news and developments.
Doctors of the World – Project Yemen
Good news – ALBOMED construction project can be continued
Headoffice
ALBOMED GmbH
Hildebrandstr. 11
90592 Schwarzenbruck | Germany
info@albomed.eu
+49 (0) 9183 95 69 82-0
Facility UNNA I | Logistic center
Otto-Brenner-Str. 7
59425 Unna | Germany
Facility UNNA II | Production
Isaac-Newton-Str. 7
59423 Unna | Germany